This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): E06, E 06, S2G6T-1, S2G6T-2, S2G6T-3, S2G6T-4
Description: E-06 is a topical cream fixed-dose combination, containing an antifungal agent and a mid-potency steroid, under development by Sol-Gel Technologies.
Pink Sheet FDA Performance Tracker: User Fee Goal Dates
Additional information available to subscribers only: